Health knowledge made personal
WellPage for Renal Kidney Cancer
+ Bookmark › Share
Search posts:

Renal Kidney Cancer - Articles

Surgery improves kidney cancer s ... by Dr. Rubens D. Medical Doctor Posted Mon 29 Dec 2008 6:02pm Surgery improves kidney cancer survival: study NEW YORK, 26 dec 2008– Surgical removal of the kidney -- a procedure known as nephrectomy -- improves survival in patients with locally advanced renal cell carcinoma, the most common form of kidney cancer. Dr. Pierre I. Karakiewicz from University of Montreal and colleagues determined surviva ... Read on »
Featured Clinical Trial: Targeting Tumor Metabolism in Papillary Kidney Cancers by Posted Tue 14 Dec 2010 12:00am Targeting Tumor Metabolism in Papillary Kidney Cancers Name of the Trial Phase II Study of Bevacizumab and Erlotinib in Subjects with Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer (NCI-10-C-0114). See the protocol summary . ... Read on »
FDA Approves Inlyta (Axitinib) to Treat a Type of Advanced Kidney Cancer by Medline Plus Posted Mon 30 Jan 2012 8:01am Renal cell carcinoma is a type of kidney cancer that starts in the lining of very small tubes in the kidney. Inlyta works by blocking certain proteins called kinases that play a role in tumor growth and cancer progression. Inlyta is a pill that patients take twice a day. “This is the seventh drug that has been approved for t ... Read on »
Vaccine Disappoints for Preventing Kidney Cancer Recurrence by kenny Posted Tue 24 Nov 2009 10:03pm Home » 24 November 2009 40 views No Comment protect ur eyes A randomized trial that studied the impact of the new vitespen vaccine, administered after surgery for kidney cancer , failed to demonstrate an increase in recurrence-free survival (RFS). More research is needed, according to the study a ... Read on »
FDA Approves New Treatment for Advanced Form of Kidney Cancer by Health: Hearsay & Headlines Posted Tue 20 Oct 2009 10:04pm The U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be approved for kidney cancer since 2005. Votrient is an oral medication that interferes with angiogenesis, the growth of new blood vessels needed for solid tumors to grow and survive. Votrient is intended for people with advanced renal cell carci ... Read on »
Kidney cancer by Healthy Solutions Patient Expert Posted Mon 27 Jun 2011 9:05am BBC News Tony Blacker What is kidney cancer? There are several types of kidney cancer. Renal cell carcinoma (RCC) is the most common type in adults, responsible for approximately 80 per cent of cases. Kidney cancer symptoms Many people with kidney cancer have no symptoms at first, especially when the cancer is small. The a ... Read on »
Kidney cancer linked to mutated gene by Healthy Solutions Patient Expert Posted Sun 08 Apr 2012 12:10am BBC News   Scientists think they're close to understanding all of the abnormal genes which cause kidney cancer A mutated gene has been found in a third of patients with the most common form of kidney cancer. The researchers said the discovery of a second major gene linked to renal cancer was a major a ... Read on »
Treatment options for Recurrent Kidney Cancer by kenny Posted Fri 27 Nov 2009 10:03pm Home » 27 November 2009 398 views No Comment protect ur eyes Overview Recurrent kidney cancer is cancer that has recurred (come back) after it has been treated. The cancer may come back many years after initial treatment, in the kidney or in other parts of the body, such as the lungs or bone ... Read on »
The kidney cancer has returned by akontarinis Posted Wed 04 Nov 2009 10:05pm So, my old enemy has returned. First, a quick background. I was diagnosed early in 2007 with a smallish renal cell tumor in my left kidney (about 5.5cm) and had the kidney promptly removed at the famous Brigham and Women’s Hospital in Boston. The pathology reports came back with a reading of stage 1, grade 2. Pretty small and very early f ... Read on »
Featured Clinical Trial: Combining Second-Line Targeted Therapies for Advanced Kidney Cancer by Posted Sat 18 Jun 2011 10:23pm Combining Second-Line Targeted Therapies for Advanced Kidney Cancer Name of the Trial Phase III Randomized Study of Everolimus with Versus without Bevacizumab in Patients with Advanced Renal Cell Carcinoma that Progressed after First-line Treatment with Tyrosine Kinase Inhibitors (CALGB-90802). See the protoc ... Read on »